Peer review reports
From: Severe inflammatory disease activity 14 months after cessation of Natalizumab in a patient with Leber’s optic neuropathy and multiple sclerosis – a case report
| Original Submission |
| 2 Jul 2016 |
Submitted |
Original manuscript
|
|
Author responded |
Author comments
|
|
Reviewed |
Reviewer Report
|
| Resubmission - Version 2 |
|
Submitted |
Manuscript version 2
|
|
Author responded |
Author comments
|
| Resubmission - Version 3 |
|
Submitted |
Manuscript version 3
|
| Publishing |
| 14 Oct 2016 |
Editorially accepted |
|
| 18 Oct 2016 |
Article published |
10.1186/s12883-016-0720-2
|
Learn about peer review
